XML 39 R30.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Revenue Recognition - Additional Information (Detail) - Genzyme Corporation - USD ($) $ in Millions | 12 Months Ended
--- | ---
Dec. 31, 2024 | Dec. 31, 2023
Revenue Recognition Milestone Method [Line Items] |  |
Payment for development milestone | $ 1.0 |
Recognized revenue |  | $ 1.0

X
- Definition Agreement payments for development milestones. + References No definition available. + Details
Name: | mnov_AgreementPaymentsForDevelopmentMilestones
Namespace Prefix: | mnov_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8 + Details
Name: | us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_RevenueRecognitionMilestoneMethodLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnov_GenzymeCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |